Outset Medical Inc (OM NASDAQ) stock market data APIs
$4.0664
0.11(2.7%)
as of October 9, 2026
Try our APIs with
free plan!
Outset Medical Inc Financial Data Overview
Price chart is built with
Anychart
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Prev. Close
4.0664
Open
4.1772
High
4.2657
Low
4.053
52 wk Range
2.841-15.94
Market Cap
76 129 K
Shares Outstanding
18 797 K
Revenue
118 M
EPS
-0.94
Beta
1.989
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Outset Medical Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Outset Medical Inc data using free add-ons & libraries
Get Outset Medical Inc Fundamental Data
Outset Medical Inc Fundamental data includes:
- Net Revenue: 118 M
- EBITDA: -62 731 000
- Earnings Per Share: -4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-06
- EPS/Forecast: -0.88
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Outset Medical Inc News
New
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
DaVita Inc. DVA has been gaining from strong execution across its Integrated Kidney Care ("IKC") platform, improving treatment volumes and investments in technology and clinical innovation. The optimi...
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
Hims & Hers Health HIMS has entered the last quarter of 2026 with strong momentum from weight loss offerings, international expansion and AI-enabled care. However, gross margin pressure from changing ...
Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?
Fresenius Medical Care AG FMS is accelerating the U.S. rollout of its 5008X CAREsystem as it pushes high-volume hemodiafiltration, or HVHDF, into more clinics. The deployment adds a technology-led gro...
Outset Medical (OM) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chair and Chief Executive Officer - Leslie Trigg Chief Financial Officer - Renee Gaeta Investor Relatio...
Get Outset Medical Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.